NEXVET BIOPHARMA PUBLIC LIMITED COMPANY (an Irish public limited company) [—] Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • January 26th, 2015 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY, ISSUER AND TRUSTEE INDENTURE DATED AS OF [●], 20[●] DEBT SECURITIESIndenture • April 22nd, 2016 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 20[●], among Nexvet Biopharma public limited company, an Irish public limited company (the “Company”), and [●], as trustee (the “Trustee”):
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY AND [●], AS WARRANT AGENT FORM OF PREFERENCE SHARES WARRANT AGREEMENT DATED AS OF [●], 20[●]Warrant Agreement • April 22nd, 2016 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
THIS PREFERENCE SHARES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NEXVET BIOPHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY AND [●], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [●], 20[●]Warrant Agreement • April 22nd, 2016 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NEXVET BIOPHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
AGREEMENT between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDAgreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations • England and Wales
LICENSE AGREEMENT between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDLicense Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations • England and Wales
LONZA SALES AG incorporated and registered in Switzerland whose registered office is at Muenchensteinerstrasse 38, CH-4002, Basel, Switzerland (hereinafter referred to as “Lonza”), and
LICENCE AGREEMENT between LONZA SALES AG. and NEXVET BIOPHARMA PTY LTDLicence Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations • England and Wales
LONZA SALES AG incorporated and registered in Switzerland whose registered office is at Muenchensteinerstrasse 38, CH-4002, Basel, Switzerland (hereinafter referred to as “Lonza”), and
AMENDMENT No. 1 TO the AGREEMENT dated 16 December 2013 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTD (NV02)The Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
AMENDMENT No. 2 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDThe Agreement • September 5th, 2014 • NEXVET BIOPHARMA LTD • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
AMENDMENT No. 10 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDThe Agreement • January 26th, 2015 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
AMENDMENT No. 1 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDThe Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
AMENDMENT No. 6 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDThe Agreement • November 19th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
DATED APRIL 13, 2017 ZOETIS INC AND NEXVET BIOPHARMA LIMITED EXPENSES REIMBURSEMENT AGREEMENTExpenses Reimbursement Agreement • April 18th, 2017 • Nexvet Biopharma PLC • Pharmaceutical preparations
DATED APRIL 13, 2017 NEXVET BIOPHARMA PUBLIC LIMITED COMPANY ZOETIS INC. ZOETIS BELGIUM S.A., TRANSACTION AGREEMENTTransaction Agreement • April 18th, 2017 • Nexvet Biopharma PLC • Pharmaceutical preparations
SPECIFIC DISTRIBUTION AGREEMENT FOR NV-01 PRODUCTSpecific Distribution Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
VIRBAC, a company organized under the law of FRANCE, with registered office at 1ère avenue 2065 M – L.I.D., 06516, Carros, France - registered under number 417 350 311 RCS at Grasse, France, acting for itself and its Affiliates, herein duly represented by Christian Karst, Member of the Executive Board,
AMENDMENT No. 2 TO the AGREEMENT dated 16 December 2013 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTD (NV02)The Agreement • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
AMENDMENT No. 8 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDConfidential • December 30th, 2014 • Nexvet Biopharma PLC • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY REGISTRATION RIGHTS AGREEMENT 22 January 2015Registration Rights Agreement • January 26th, 2015 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 22 day of January 2015, by and among Nexvet Biopharma Public Limited Company, an Irish public limited company of 88 Harcourt Street, Dublin 2, Ireland (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any additional purchaser that becomes a party to this Agreement in accordance with Section 3.10 hereof.
AMENDMENT No. 3 TO the AGREEMENT dated 21 December 2012 between LONZA SALES AG and NEXVET BIOPHARMA PTY LTDThe Agreement • September 5th, 2014 • NEXVET BIOPHARMA LTD • Pharmaceutical preparations
*** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
